Merck & Co. stock: Baker to become lead director in January
Published on 11/19/2026 at 16:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBoard succession takes shape
- Thomas H. Glocer plans to leave Merck's board at the annual shareholder meeting.
- Douglas M. Baker brings governance and operating experience to the lead director role.
Board succession takes shape
Merck said on November 18 that Thomas H. Glocer intends to retire from its board at the annual shareholder meeting in May 2027. The company also appointed Douglas M. Baker, Jr. as independent lead director, effective January 1, according to the Merck announcement.
Baker will succeed Glocer in the role. Merck said Baker has served on the board since 2022 and previously was chairman and chief executive officer of Ecolab. The announcement described the change as a planned governance transition.
What changes for investors
The transition changes the board's independent leadership while leaving the chief executive and chairman roles with Rob Davis. Glocer's retirement is scheduled for the shareholder meeting rather than taking effect immediately, so the next formal step is the company's annual meeting process.
Merck & Co. stock traded at 122.63 euros on Lang & Schwarz at 16:05 CET on Thursday, November 19, 2026.
Merck & Co. at a glance
- Company: Merck & Co.
- ISIN: US58933Y1055
- Ticker: MRK
- Trading venue: Lang & Schwarz
- Price: 122.63 euros at 16:05 CET on November 19, 2026
For broader market developments, see Current market reports.
